Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Analysis of pluripotency transcription factor interactions reveals preferential binding of NANOG to SOX2 rather than NANOG or OCT4

View through CrossRef
ABSTRACT The pluripotency transcription factors (TFs) Nanog, Sox2, and Oct4 are at the centre of the gene regulatory network that controls cell identity in embryonic stem (ES) cells. However, the mechanisms by which these factors control cell fate, and their interactions with one another are not fully understood. Here we combine biophysical and novel biochemical assays to assess how these factors interact with each other quantitatively. A confocal microscopy method to detect binding of a target protein to a fluorescently labelled partner (coimmunoprecipitated bead imaging microscopy [CBIM]) is presented and used to demonstrate homotypic binding of Nanog and heterotypic binding between Nanog and Sox2 and between Nanog and Oct4. Using fluorescence correlation spectroscopy we show that in solution, Nanog but not Oct4 or Sox2 can form homomultimers. However, both Sox2 and Oct4 can form heterotypic multimers with Nanog in a manner that depends on the presence of tryptophan residues within the Nanog tryptophan repeat. Fluorescence Cross Correlation Spectroscopy shows the affinity of Nanog for dimer formation is in the order Sox2 > Nanog > Oct4. Importantly, live cell analysis demonstrates the existence of Nanog homomultimers in vivo . Together these findings extend understanding of the molecular interactions occurring between these central mediators of the pluripotency gene regulatory network at the single-molecule level.
Title: Analysis of pluripotency transcription factor interactions reveals preferential binding of NANOG to SOX2 rather than NANOG or OCT4
Description:
ABSTRACT The pluripotency transcription factors (TFs) Nanog, Sox2, and Oct4 are at the centre of the gene regulatory network that controls cell identity in embryonic stem (ES) cells.
However, the mechanisms by which these factors control cell fate, and their interactions with one another are not fully understood.
Here we combine biophysical and novel biochemical assays to assess how these factors interact with each other quantitatively.
A confocal microscopy method to detect binding of a target protein to a fluorescently labelled partner (coimmunoprecipitated bead imaging microscopy [CBIM]) is presented and used to demonstrate homotypic binding of Nanog and heterotypic binding between Nanog and Sox2 and between Nanog and Oct4.
Using fluorescence correlation spectroscopy we show that in solution, Nanog but not Oct4 or Sox2 can form homomultimers.
However, both Sox2 and Oct4 can form heterotypic multimers with Nanog in a manner that depends on the presence of tryptophan residues within the Nanog tryptophan repeat.
Fluorescence Cross Correlation Spectroscopy shows the affinity of Nanog for dimer formation is in the order Sox2 > Nanog > Oct4.
Importantly, live cell analysis demonstrates the existence of Nanog homomultimers in vivo .
Together these findings extend understanding of the molecular interactions occurring between these central mediators of the pluripotency gene regulatory network at the single-molecule level.

Related Results

NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades
NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades
NANOG, as a key regulator of pluripotency and acting synergistically with other factors, has been described as a crucial transcription factor in various types of cancer. In meningi...
Glioma SOX2 expression decreased after adjuvant therapy
Glioma SOX2 expression decreased after adjuvant therapy
Abstract Objectives: SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown s...
Glioma SOX2 expression decreased after adjuvant therapy
Glioma SOX2 expression decreased after adjuvant therapy
Abstract Objectives SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown s...
Glioma SOX2 expression decreased after adjuvant therapy
Glioma SOX2 expression decreased after adjuvant therapy
Abstract SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown so far. Few p...
Enhancing Sox/Oct cooperativity induces higher-grade developmental reset
Enhancing Sox/Oct cooperativity induces higher-grade developmental reset
ABSTRACT The discovery of induced pluripotent stem cell (iPSC) technology by Shinya Yamanaka has truly enabled the stem cell field. After 16 years of intense resear...
Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
AbstractMany renal cancer patients experience disease recurrence after combined treatments or immunotherapy due to permanence of cancer stem cells (CSCs). This study was conducted ...
TEAD4/YAP1/WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage
TEAD4/YAP1/WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage
In mice, pluripotent cells are thought to derive from cells buried inside the embryo around the 16-cell stage. Sox2 is the only pluripotency gene known to be expressed specifically...
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation
Abstract Global studies of the transcriptome reveal that approximately half of human transcriptional units (genes) encode solely non-protein-coding RNAs (ncRNAs), wh...

Back to Top